26P Circulating osteocalcin-positive cells, as a novel biomarker for monitoring the therapeutic effects on bone metastasis

MLA

M.J. Kim, et al. “26P Circulating Osteocalcin-Positive Cells, as a Novel Biomarker for Monitoring the Therapeutic Effects on Bone Metastasis.” Annals of Oncology, vol. 33, Nov. 2022, pp. S1439–40. EBSCOhost, https://doi.org/10.1016/j.annonc.2022.10.035.

APA

M.J. Kim, H.S. Shin, K-H. Lee, & S.W. Cho. (2022). 26P Circulating osteocalcin-positive cells, as a novel biomarker for monitoring the therapeutic effects on bone metastasis. Annals of Oncology, 33, S1439–S1440. https://doi.org/10.1016/j.annonc.2022.10.035

Chicago

M.J. Kim, H.S. Shin, K-H. Lee, and S.W. Cho. 2022. “26P Circulating Osteocalcin-Positive Cells, as a Novel Biomarker for Monitoring the Therapeutic Effects on Bone Metastasis.” Annals of Oncology 33 (November): S1439–40. doi:10.1016/j.annonc.2022.10.035.